Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386563 · ClinicalTrials.gov registry record · NA
taVNS on Pupillary Response and Perceptual Learning
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05386563 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 12 participants.
The verdict
NCT05386563, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study has two parts. The study team will evaluate transcutaneous auricular vagal nerve stimulation (taVNS) and two sham settings during a passive task while measuring pupillary response. Second, the study team will assign either taVNS, sham, or no intervention during a go/no-go task and evaluate perceptual learning over three sessions which will also include measuring the pupillary response and electroencephalogram (EEG).
Interventions
- PROCEDURE Transcutaneous Auricular Vagal Nerve Stimulation (taVNS)
- PROCEDURE Sham Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2025-07-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05386563
The ClinicalTrials.gov registry entry for NCT05386563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) is the first listed.
NCT05386563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05386563 about?
NCT05386563 is a clinical study titled "taVNS on Pupillary Response and Perceptual Learning". This study has two parts. The study team will evaluate transcutaneous auricular vagal nerve stimulation (taVNS) and two sham settings during a passive task while measuring pupillary response. Second, the study team will assign either taVNS, sham, or no intervention during a go/no-go task and evaluat...
What is the current status of trial NCT05386563?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-05-18. Estimated completion is 2025-07-09.
What interventions are being tested in trial NCT05386563?
The interventions under investigation include: Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) (PROCEDURE), Sham Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT05386563?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.